telehealth for semaglutide Novo Nordisk Expands GLP-1 Access

Copper toxicity concerns exist with prolonged GHK-Cu use, though clinical cases remain extremely rare at therapeutic doses

Vitamin D increases muscle mass, which can burn more calories

Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy

Its Not the Medication ItselfIts the Weight Loss Heres the most important thing to understand: GLP-1 medications dont directly cause hair loss

The contribution of immune mechanisms in PD is also corroborated by the observation that ablation of MHC class II renders mice more resistant to MPTP toxicity (Martin et al., 2016)

0View community protocols Aleniglipron is an investigational oral small molecule GLP-1 receptor agonist developed by Structure Therapeutics